Schroders Capital
VC Fund
London, United Kingdom
Schroders Capital is a VC fund in London focused on Biotechnology and Health Care. Schroders Capital helps clients with the management of their investments.
- Total investments:
- 52
- Last investment:
- Lead investor:
- 27%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Schroders Capital invests in
BiotechnologyHealth CareTherapeuticsSoftwareMedical
Stages Schroders Capital invests in
Series ASeries CSeries BDebt FinancingFunding Round
Countries Schroders Capital invests in
United KingdomUnited StatesSwitzerlandThe NetherlandsCanada
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jérôme Janssen
|
|||
Augustin Segard
|
|||
|
Steven Yang
|
|||
Tim Creed
|
|||
1 more contact available
Investment Focus
Industry
- Biotechnology 14 (27%)
- Health Care 10 (19%)
- Therapeutics 8 (15%)
- Software 4 (8%)
- Medical 3 (6%)
Stage
- Series A 6 (12%)
- Series C 6 (12%)
- Series B 5 (10%)
- Debt Financing 5 (10%)
- Funding Round 3 (6%)
Country
- United Kingdom 8 (15%)
- United States 7 (13%)
- Switzerland 6 (12%)
- The Netherlands 3 (6%)
- Canada 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jérôme Janssen
Co-Head of Infrastructure Equity Investment
|
Co-Head of Infrastructure Equity Investment | Total investments: 1 | Find email | |
|
Augustin Segard
Head of Junior Infrastructure Debt
|
Head of Junior Infrastructure Debt | Total investments: 1 | Find email | |
|
Steven Yang
Head of Global Venture Investments
|
Head of Global Venture Investments | Total investments: 1 | Find email | |
|
Tim Creed
Managing Director
|
Managing Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Suno
|
Suno is a music start-up that enables anyone to make the songs they want. The company aims to help people rediscover the joy of play and exploration. | $400M / Series D / Jun 03, 2026 | |
Multiverse
|
Multiverse is a tech startup that seeks to provide an alternative to university training. Multiverse ensures young people have access to the best career-focused apprenticeships on offer.Multiverse empowers and supports people to create their own realities as they journey through a fulfilling career. Multiverse is a true alternative to a one-trackuniversity route and often uninspiring corporate training. | $70M / Venture - Series Unknown / May 15, 2026 | |
|
Multiverse
|
Multiverse is a tech startup that seeks to provide an alternative to university training. Multiverse ensures young people have access to the best career-focused apprenticeships on offer.Multiverse empowers and supports people to create their own realities as they journey through a fulfilling career. Multiverse is a true alternative to a one-trackuniversity route and often uninspiring corporate training. | $70M / Series E / May 15, 2026 | |
Solace
|
Solace helps large enterprises become modern and real-time by giving them everything they need to make their business operations and customer interactions event-driven. With PubSub+, the market’s first and only event management platform, the company provides a comprehensive way to create, document, discover and stream events from where they areproduced to where they need to be consumed – securely, reliably, quickly, and guaranteed. Behind Solace technology is the world’s leading group of data movement experts, with nearly 20 years of experience helping global enterprises solve some of the most demanding challenges in a variety of industries – from capital markets, retail, and gaming to space, aviation, and automotive. Established enterprises such as SAP, Barclays and the Royal Bank of Canada, multinational automobile manufacturers such as Renault and Groupe PSA, and industry disruptors such as Jio use Solace’s advanced event broker technologies to modernize legacy applications, deploy modern microservices, and build an event mesh to support their hybrid cloud, multi-cloud and IoT architectures. Learn more at solace.com. | $790M / Venture - Series Unknown / May 05, 2026 | |
|
Solace
|
Solace helps large enterprises become modern and real-time by giving them everything they need to make their business operations and customer interactions event-driven. With PubSub+, the market’s first and only event management platform, the company provides a comprehensive way to create, document, discover and stream events from where they areproduced to where they need to be consumed – securely, reliably, quickly, and guaranteed. Behind Solace technology is the world’s leading group of data movement experts, with nearly 20 years of experience helping global enterprises solve some of the most demanding challenges in a variety of industries – from capital markets, retail, and gaming to space, aviation, and automotive. Established enterprises such as SAP, Barclays and the Royal Bank of Canada, multinational automobile manufacturers such as Renault and Groupe PSA, and industry disruptors such as Jio use Solace’s advanced event broker technologies to modernize legacy applications, deploy modern microservices, and build an event mesh to support their hybrid cloud, multi-cloud and IoT architectures. Learn more at solace.com. | $790M / Secondary Market / May 05, 2026 | |
Vinted
|
Vinted operates an online marketplace intended to make second-hand the first choice. Its platform offers a peer-to-peer marketplace for girls and women to buy, sell, and swap clothes with an online chatting feature, enabling users to shop with ease at low cost. It was founded in 2008 and headquartered in Apskritis, Lithuania. | $1B / Secondary Market / Apr 27, 2026 | |
SABSEG GROUP
|
SABSEG GROUP provides insurance brokerage services, focusing on consolidating and growing by incorporating new brokerages. The company operates in the insurance industry and is backed by Miura Partners. SABSEG GROUP aims to reinforce its position as an independent broker in the Iberian Peninsula. | Private Equity / Mar 09, 2026 | |
Wayve
|
Wayve develops autonomous driving technology using end-to-end deep learning models that enable vehicles to navigate complex urban environments. The company builds AI software that learns directly from data collected through cameras and sensors, reducing reliance on high-definition maps and rule-based systems. Its approach focuses on embodiedintelligence, where the system improves driving performance through large-scale real-world training and simulation. Wayve partners with automotive manufacturers and fleet operators to integrate its driving software into production vehicles. The platform is designed to adapt to different geographies and driving conditions through continuous learning and model refinement. | $1.3B / Series D / Feb 24, 2026 | |
Kainova Therapeutics
|
Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identifyorthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs. | $23.5M / Series B / Feb 09, 2026 | |
Tem-Energy
|
Until now, businesses have had to buy power via Big Energy putting up with overpricing, sapping levels of service and glacial innovation. Now with tem. any company can buy Renewable Energy Direct. This allows businesses to save on energy costs whilst renewable generators are rewarded. | $75M / Series B / Jan 26, 2026 | |
| See all 52 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
Health Care VC Funds
32,370 investors
FAQ
What does Schroders Capital invest in?
Schroders Capital invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Series A and Series C stage. Most of the 52 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Schroders Capital?
Public channels for Schroders Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Schroders Capital?
The team at Schroders Capital includes Jérôme Janssen (Co-Head of Infrastructure Equity Investment), Augustin Segard (Head of Junior Infrastructure Debt) and Steven Yang (Head of Global Venture Investments). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
